{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:51:29Z","timestamp":1762505489165},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0005747","type":"journal-article","created":{"date-parts":[[2009,5,29]],"date-time":"2009-05-29T21:50:00Z","timestamp":1243633800000},"page":"e5747","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":54,"title":["Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6\/2 Mouse Model of Huntington's Disease"],"prefix":"10.1371","volume":"4","author":[{"given":"Caroline L.","family":"Benn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Mariner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jude","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Moffitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Mielcarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian P.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2009,6,1]]},"reference":[{"key":"ref1","article-title":"Huntington&apos;s Disease. 3rd ed","author":"GP Bates","year":"2002"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington&apos;s disease chromosomes. The Huntington&apos;s Disease Collaborative Research Group.","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.","volume":"277","author":"M DiFiglia","year":"1997","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington&apos;s disease: relationship to neuropathology.","volume":"19","author":"CA Gutekunst","year":"1999","journal-title":"J Neurosci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.","volume":"87","author":"L Mangiarini","year":"1996","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.","volume":"90","author":"SW Davies","year":"1997","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington&apos;s disease mutation.","volume":"19","author":"RJ Carter","year":"1999","journal-title":"J Neurosci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington&apos;s disease mutation.","volume":"19","author":"LA Lione","year":"1999","journal-title":"J Neurosci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington&apos;s disease transgenic mice.","volume":"490","author":"EC Stack","year":"2005","journal-title":"J Comp Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington&apos;s disease.","volume":"83","author":"JH Cha","year":"2007","journal-title":"Prog Neurobiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/hmg\/ddi192","article-title":"Gene expression in Huntington&apos;s disease skeletal muscle: a potential biomarker.","volume":"14","author":"AD Strand","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington&apos;s disease brain.","volume":"15","author":"A Hodges","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin&apos;s effects on striatal gene expression in mice recapitulate changes observed in human Huntington&apos;s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.","volume":"16","author":"A Kuhn","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H","article-title":"Roles of histone acetyltransferases and deacetylases in gene regulation.","volume":"20","author":"MH Kuo","year":"1998","journal-title":"Bioessays"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.febslet.2004.12.007","article-title":"Transcriptional regulation and the role of diverse coactivators in animal cells.","volume":"579","author":"RG Roeder","year":"2005","journal-title":"FEBS Lett"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.","volume":"17","author":"P Gallinari","year":"2007","journal-title":"Cell Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington&apos;s disease protein interacts with p53 and CREB-binding protein and represses transcription.","volume":"97","author":"JS Steffan","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","first-page":"560","article-title":"Mutant huntingtin represses CBP, but not p300, by binding and protein degradation.","volume":"30","author":"SY Cong","year":"2005","journal-title":"Mol Cell Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1523\/JNEUROSCI.3344-05.2006","article-title":"Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.","volume":"26","author":"EA Bates","year":"2006","journal-title":"J Neurosci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"15179","DOI":"10.1073\/pnas.261400698","article-title":"Histone deacetylase inhibitors reduce polyglutamine toxicity.","volume":"98","author":"A McCampbell","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"13201","DOI":"10.1073\/pnas.191498198","article-title":"Altered transcription in yeast expressing expanded polyglutamine.","volume":"98","author":"RE Hughes","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.","volume":"413","author":"JS Steffan","year":"2001","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington&apos;s disease.","volume":"100","author":"E Hockly","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington&apos;s disease.","volume":"280","author":"G Gardian","year":"2005","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nrn1989","article-title":"Histone deacetylase inhibitors as therapeutics for polyglutamine disorders.","volume":"7","author":"R Butler","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/156720506778249407","article-title":"Histone deacetylase inhibitors: a novel therapeutic approach to Huntington&apos;s disease (complex mechanism of neuronal death).","volume":"3","author":"G Sadri-Vakili","year":"2006","journal-title":"Curr Alzheimer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.","volume":"7","author":"AG Kazantsev","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington&apos;s disease transgenic mice.","volume":"105","author":"EA Thomas","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington&apos;s disease models.","volume":"16","author":"G Sadri-Vakili","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrm2346","article-title":"The Rpd3\/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men.","volume":"9","author":"XJ Yang","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action.","volume":"26","author":"WS Xu","year":"2007","journal-title":"Oncogene"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","article-title":"Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington&apos;s disease.","volume":"17","author":"J Pallos","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jmb.2004.02.006","article-title":"Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.","volume":"338","author":"IV Gregoretti","year":"2004","journal-title":"J Mol Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1158\/1535-7163.MCT-07-0251","article-title":"Histone deacetylase inhibitors selectively suppress expression of HDAC7.","volume":"6","author":"M Dokmanovic","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2006.05.040","article-title":"Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10.","volume":"126","author":"S Chang","year":"2006","journal-title":"Cell"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/bcmd.2000.0376","article-title":"Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers.","volume":"27","author":"VM Richon","year":"2001","journal-title":"Blood Cells Mol Dis"},{"key":"ref37","article-title":"Zn(II)-dependent histone deacetylase inhibitors: Suberoylanilide hydroxamic acid and trichostatin A.","author":"R Codd","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1128\/MCB.23.19.6993-7004.2003","article-title":"Autoregulation of mouse histone deacetylase 1 expression.","volume":"23","author":"B Schuettengruber","year":"2003","journal-title":"Mol Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1038\/sj.onc.1210613","article-title":"Class IIa histone deacetylases: regulating the regulators.","volume":"26","author":"M Martin","year":"2007","journal-title":"Oncogene"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse.","volume":"61","author":"E Hockly","year":"2003","journal-title":"Brain Res Bull"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.nbd.2005.07.007","article-title":"Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington&apos;s disease.","volume":"21","author":"E Hockly","year":"2006","journal-title":"Neurobiol Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes.","volume":"72","author":"B Woodman","year":"2007","journal-title":"Brain Res Bull"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1073\/pnas.0737363100","article-title":"Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway.","volume":"100","author":"H Ryu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-3-17","article-title":"Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington&apos;s disease.","volume":"3","author":"CL Benn","year":"2008","journal-title":"Mol Neurodegener"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/emboj\/21.11.2672","article-title":"Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression.","volume":"21","author":"G Lagger","year":"2002","journal-title":"Embo J"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02686117","article-title":"Distribution of histone deacetylases 1\u201311 in the rat brain.","volume":"31","author":"RS Broide","year":"2007","journal-title":"J Mol Neurosci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1139\/o01-032","article-title":"Class II histone deacetylases: structure, function, and regulation.","volume":"79","author":"NR Bertos","year":"2001","journal-title":"Biochem Cell Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"47496","DOI":"10.1074\/jbc.M107631200","article-title":"Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7.","volume":"276","author":"HY Kao","year":"2001","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"41966","DOI":"10.1074\/jbc.M406320200","article-title":"Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity.","volume":"279","author":"H Kato","year":"2004","journal-title":"J Biol Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jcb.20179","article-title":"Regulation of histone deacetylase activities.","volume":"93","author":"N Sengupta","year":"2004","journal-title":"J Cell Biochem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"13762","DOI":"10.1074\/jbc.M413396200","article-title":"Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation.","volume":"280","author":"M Parra","year":"2005","journal-title":"J Biol Chem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1101\/gad.1513107","article-title":"Myosin phosphatase dephosphorylates HDAC7, controls its nucleocytoplasmic shuttling, and inhibits apoptosis in thymocytes.","volume":"21","author":"M Parra","year":"2007","journal-title":"Genes Dev"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1091\/mbc.E07-11-1203","article-title":"Signal-dependent regulation of transcription by histone deacetylase 7 involves recruitment to promyelocytic leukemia protein nuclear bodies.","volume":"19","author":"C Gao","year":"2008","journal-title":"Mol Biol Cell"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1128\/MCB.00874-08","article-title":"Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation.","volume":"28","author":"C Gao","year":"2008","journal-title":"Mol Cell Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1016\/j.febslet.2006.08.038","article-title":"CRM1 mediates nuclear export of HDAC7 independently of HDAC7 phosphorylation and association with 14-3-3s.","volume":"580","author":"C Gao","year":"2006","journal-title":"FEBS Lett"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1161\/ATVBAHA.108.172528","article-title":"VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis.","volume":"28","author":"CH Ha","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.2174\/092986708786242796","article-title":"The structure and function of histone deacetylases: the target for anti-cancer therapy.","volume":"15","author":"Y Zhang","year":"2008","journal-title":"Curr Med Chem"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1073\/pnas.0708455105","article-title":"Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis.","volume":"105","author":"M Martin","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1359\/jbmr.071104","article-title":"Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.","volume":"23","author":"ED Jensen","year":"2008","journal-title":"J Bone Miner Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1074\/jbc.M800586200","article-title":"Bone morphogenic protein 2 activates protein kinase d to regulate histone deacetylase 7 localization and repression of runx2.","volume":"284","author":"ED Jensen","year":"2009","journal-title":"J Biol Chem"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"11355","DOI":"10.1074\/jbc.M707362200","article-title":"Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity.","volume":"283","author":"A Schuetz","year":"2008","journal-title":"J Biol Chem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1101\/gad.14.1.55","article-title":"Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression.","volume":"14","author":"HY Kao","year":"2000","journal-title":"Genes Dev"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0005747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T11:13:09Z","timestamp":1685013189000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0005747"}},"subtitle":[],"editor":[{"given":"Silvana","family":"Gaetani","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,6,1]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,6,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0005747","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,1]]}}}